GlassScriptPhysician profile
Carrie Ball
NPI 1902099617
$3,006.99
in general payments reported to CMS, 2019-2025
30 companies · $325 in 2025
The $325 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255 · 2020: $308 · 2021: $477 · 2022: $762 · 2023: $547 · 2024: $333 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,189 · Entertainment: $15.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,189.04 |
| Entertainment | $15.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $716.39 | 2019-2024 | Lo Loestrin Fe, Orilissa |
| Bayer Healthcare Pharmaceuticals INC. | $212.44 | 2019-2023 | |
| Exeltis, USA INC. | $192.90 | 2020-2025 | Slynd, Nuvessa |
| Hologic Sales and Service, LLC | $176.70 | 2019-2025 | Novasure, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Sumitomo Pharma America, INC. | $160.19 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $155.33 | 2021-2022 | |
| Organon LLC | $125.15 | 2021-2025 | Nexplanon |
| Astellas Pharma US INC | $113.33 | 2022-2025 | Veozah, Myrbetriq |
| Evofem Biosciences, INC. | $99.80 | 2020-2025 | Phexxi, Solosec, Phexx |
| Renovia INC | $95.37 | 2019 | |
| Pfizer INC. | $91.07 | 2022-2024 | |
| Exact Sciences Corporation | $89.61 | 2023-2025 | Cologuard Collection Kit |
| Mayne Pharma Commercial LLC | $88.03 | 2022-2024 | |
| Medicem INC. | $88.01 | 2020-2022 | |
| Coopersurgical, INC. | $73.25 | 2020-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $71.66 | 2019-2021 | |
| Agile Therapeutics, INC. | $60.83 | 2022-2024 | Twirla |
| Avion Pharmaceuticals | $55.24 | 2020-2021 | |
| Allergan, INC. | $51.19 | 2019-2020 | |
| Therapeuticsmd, INC. | $45.41 | 2019-2022 | |
| Sage Therapeutics, LLC | $41.71 | 2024-2025 | Zurzuvae |
| Lupin INC. | $34.89 | 2019-2020 | |
| Amgen INC. | $30.03 | 2020-2023 | Evenity |
| Smith+Nephew, INC. | $28.59 | 2024 | Pico 7 |
| Dexcom, INC. | $24.97 | 2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $22.27 | 2023 | V-Loc 180 |
| Aspira Women'S Health INC | $18.96 | 2022 | |
| Argentum Medical | $15.52 | 2025 | |
| Scynexis, INC. | $15.11 | 2022 | |
| Merck Sharp & Dohme LLC | $13.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Ball listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.